AI-Identified Molecule Shows Weight-Loss Effects in Animals
Researchers at Stanford have identified a natural molecule, dubbed BRP, that may offer a new approach to appetite control and weight management. The discovery was made with the help of AI, which helped scientists screen for promising biological compounds.
In animal experiments, BRP reduced food intake by as much as 50% and promoted fat loss. Its effects appeared to involve a different brain pathway from those targeted by Ozempic-like medications, suggesting that it could potentially provide more precise treatment for obesity.
The researchers also reported that BRP did not produce the common digestive side effects or significant muscle loss often associated with existing weight-loss drugs in their animal tests. These findings remain preclinical: the molecule will need to be tested in humans to establish its safety, effectiveness, and dosing.
If human trials confirm the results, BRP could broaden the range of treatments available for obesity and other conditions linked to excessive appetite and weight gain.